Skip to main content

Pfizer’s got its eye on more than the COVID-19 market

The company is already laying the groundwork for what it will look like when revenue from its COVID-19 franchise begins to wane.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.